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AMP-activated protein kinase (AMPK) plays a pivotal role in regulating cellular energy metabolism.
We previously showed that AMPKa1/ mice develop moderate anemia associated with spleno-
megaly and high reticulocytosis. Here, we report that splenectomy of AMPKa1/ mice worsened
anemia supporting evidence that AMPKa1/ mice developed a compensatory response through
extramedullary erythropoiesis in the spleen. Transplantation of bone marrow from AMPKa1/
mice into wild-type recipients recapitulated the hematologic phenotype. Further, AMPKa1/ red
blood cells (RBC) showed less deformability in response to shear stress limiting their membrane
ﬂexibility. Thus, our results highlight the crucial role of AMPK to preserve RBC integrity.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
AMP-activated protein kinase (AMPK) plays a key role in the
maintenance of cellular energy homeostasis [1]. It exists as a het-
erotrimeric complex consisting of an a catalytic subunit, and two
regulatory subunits b and c. There are a number of isoforms known
for each subunit (a1, a2, b1, b2, c1, c2, c3) which are encoded by
different genes, and which can give rise to a large variety of hetero-
trimeric combinations. Functional orthologues of AMPK are found
throughout the eukaryotes, indicating that the function of this ki-
nase complex is evolutionarily conserved. Genetic studies in lower
eukaryotes suggest that activation of AMPK allows the organism to
survive periods of starvation and could lead to subsequent exten-
sion of lifespan [2]. In multicellular eukaryotes, AMPK evolved as
a mechanism sensitive to cellular energy status, as well as to hor-
mones and cytokines to regulate whole-body energy balance and
feeding behaviour [1]. In addition and beyond the regulation of en-chemical Societies. Published by E
RM U1016, Université Paris
ue (UMR8104), Paris, France.
).ergy homeostasis, AMPK could also exert non-metabolic functions
such as maintenance of cell polarity and normal cell division, or
control of cell growth and survival [3].
Mature red blood cells (RBC) have a ﬁnite lifespan and their pro-
duction and recycling must be carefully balanced, or disease en-
sues. During their intravascular lifespan, RBC require energy to
maintain a number of vital cell functions, including maintenance
of the electrolyte gradient between plasma and red cell cytoplasm
through the activity of ATP-driven membrane pumps [4]. On en-
ergy depletion, RBC undergo suicidal cell death or eryptosis charac-
terized by cell swelling and phosphatidylserine exposure at their
surface [5]. Recent observations have revealed a role for AMPK in
the regulation of eryptosis during energy depletion. Indeed,
in vitro studies demonstrated increased percentage of RBC expos-
ing phosphatidylserine in AMPKa1/mice and higher sensitivity
to eryptosis following energy depletion [6]. Interestingly, the major
phenotypic change observed in AMPKa1/ mice is a moderate
anemia characterized by a general decline in RBC count, hemoglo-
bin concentration, hematocrit and a marked splenomegaly which
points to abnormal erythropoiesis and/or decreased RBC survival
[6–8].
In the present study, we address additional pathophysiological
aspects of RBC homeostasis in AMPKa1/ mice. We report thatlsevier B.V. All rights reserved.
Fig. 1. RBC from AMPKa1/ mice lack AMPKa1-subunit expression and show
normal morphology. (A) Expression of AMPKa1 and a2 catalytic subunits in murine
skeletal muscle, liver, RBC and RBC ghost membrane preparations. (B) Scanning
electron microscopy of RBC from WT (left) and AMPKa1/mice (right). The scale
bar represents 4 lm.
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RBC counts and hemoglobin concentration indicating compensa-
tory extramedullar erythropoiesis in the spleen. In addition,
AMPKa1/ bone marrow transplantation experiments conﬁrm
the hematologic phenotype in relation to blood parameters and
the function of AMPK in the adaptive responses of RBC homeosta-
sis. Finally, we demonstrate that AMPKa1/ RBC are less deform-
able in response to shear stress suggesting that AMPKa1 may have
a role in controlling structural ﬂexibility and integrity of RBC.
2. Materials and methods
2.1. Mouse studies
AMPKa1/ mice on a 129 Sv and C57BL/6 mixed back-
ground were generated and genotyped as described previously
[9,10]. All procedures were performed in accordance with ethical
treatment standards established by the European Convention for
the Protection of Laboratory Animals (Council of Europe, ETS
123. 1991).
2.2. Splenectomy
Splenectomy was performed on 8 week-old female mice anes-
thetized with methoxyﬂuorane. An incision was made in the left
ﬂank, and the spleen was isolated and removed after appropriate
blood vessel ligation.
2.3. Bone marrow transplantation
AMPKa1/mice backcrossed to the C57BL/6 background for 5
generations were used for these experiments. Chimera were gener-
ated by irradiating CD45.1+ mice with 2 doses of 600 cGy and
immediately reconstituting them with 4  106 CD45.2+ bone mar-
row cells isolated from the femur and tibia of WT, AMPKa1+/ or
AMPKa1/ mice. Hematological parameters of recipient mice
were analyzed 10 weeks after bone marrow transfer.
2.4. Analysis of peripheral blood and tissue iron measurements
Complete blood cell tests were performed using an ADVIA 120
hematology analyzer (Bayer). Measurements of bilirubin were exe-
cuted at the Centre d’Explorations Fonctionnelles Intégré (Institut
Claude Bernard, IFR2, Paris) using standard assays. Tissue iron con-
centrations were determined as previously described [11].
2.5. Scanning electron microscopy
Washed RBC were incubated with 2% glutaraldehyde and 2%
paraformaldehyde in 100 mM cacodylate buffer (320–340 mOsm,
pH 7.2) for 15 min. RBC were deposited onto polylysine-coated
glass cover slips, critical point-dried in CO2, sputter coated with
platinum–paladium by standard techniques, and screened with
Gemini Zeiss scanning electron microscope (University Paris Did-
erot, Paris).
2.6. Measurements of RBC deformability and osmotic fragility
RBC deformability was measured using a Laser Assisted Optical
Rotational Cell Analyzer (LORCA, Mechatronics, The Netherlands).
The change in the laserbeam diffraction pattern was detected
while RBC were subjected to increasing values of applied shear rate
(0.3–30 Pa) and a measure of the extent of cell deformation was
calculated as the deformability index. To test cell fragility, RBC
were incubated in hypotonic solutions for 45 min and percent lysis
was calculated from the absorbance at 540 nm.2.7. Statistical analysis
Results are expressed as means ± S.E.M. Comparisons between
groups were made by unpaired two-tailed Student’s t test. Differ-
ences were considered statistically signiﬁcant if P < 0.05.
3. Results
3.1. AMPKa1/ mice display a compensated anemia associated with
splenomegaly
The AMPKa1 subunit is the only AMPK catalytic isoform present
in murine (Fig. 1A) and human (data not shown) RBC. Absence of
AMPKa1 in mice results in a hemolytic disorder [6,7]. AMPKa1/
 RBC exhibit prominent anisocytosis, which coincides with an in-
crease in both the width of the RBC volume distribution (RDW) and
the number of circulating reticulocytes [7]. We have conﬁrmed
here, using scanning electron microscopy that AMPKa1/ RBC
population is heterogenous with no signiﬁcant morphological
abnormalities (Fig. 1B).
Another feature of AMPKa1/ mice that may represent pri-
mary or secondary effects of the absence of AMPKa1 is a severe
splenomegaly [6–8]. Hence, we analyzed erythropoiesis in WT
and AMPKa1/mice by measuring the frequency of the different
erythroblast subpopulations in the spleen and bone marrow. A dra-
matic increased in the early erythroblast population was observed
in the spleen (Supplementary Fig. 1A and B) and bone marrow
(Supplementary Fig. 2A and B) from AMPKa1/ mice suggesting
a rapid turnover of erythroid cells and a compensatory increase in
erythropoiesis in the absence of AMPKa1.
3.2. Splenectomized AMPKa1/ mice exhibit a more severe anemia
It was previously reported that AMPKa1/ RBC have en-
hanced phosphatidylserine exposure and reduced half-life, sug-
gesting that the anemia in AMPKa1/ mice may be secondary
to their removal by the spleen macrophages [6,7]. To test whether
AMPKa1-deﬁcient RBC accumulated speciﬁcally into the spleen,
AMPKa1/mice were splenectomized and hematological param-
eters were evaluated 40 and 90 days after. Splenectomy was
Fig. 3. Transfer of the erythroid phenotype of AMPKa1/mice after bone marrow
cells transplantation from mutant mice into lethally irradiated WT recipients. (A)
Comparison of spleen size in representative WT recipients transplanted with bone
marrow cells derived from WT (left), AMPKa1+/ (middle) or AMPKa1/ (right)
mice. (B) Perls’ iron stained section of spleen from representative WT recipients
transplanted with bone marrow cells derived from WT (left), AMPKa1+/ (middle)
or AMPKa1/ (right) mice. Original magniﬁcation, 100. (C) Iron content in the
spleen of WT recipients transplanted with bone marrow cells derived from WT
(black bar), AMPKa1+/ (dashed bar) or AMPKa1/ (empty bar) mice. Results are
expressed as means ± S.E.M. (n = 5–6); #P < 0.001 compared to WT mice; §P < 0.001
compared to AMPKa1+/ mice. (D) Iron content in the liver of WT recipients
transplanted with bone marrow cells derived from WT (black bar), AMPKa1+/
(dashed bar) or AMPKa1/ (empty bar) mice. Results are expressed as mean-
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hemoglobin concentration in AMPKa1/ but not in control mice
(Fig. 2). Further, splenectomized AMPKa1/ mice sustained
diminished reticulocyte numbers as compared to baseline but lar-
gely increased as compared to WT mice (Fig. 2), indicating that
splenic extramedullary hematopoiesis plays a compensatory role
in response to chronic anemia.
3.3. Transfer of the erythroid phenotype of AMPKa1/ mice after
bone marrow transplantation
Lethally irradiated congenic WT recipients were transplanted
with bone marrow cells from AMPKa1/, AMPKa1+/ or WT
mice and resulted in a complete repopulation of the bone marrow
with the donor red cells (data not shown). WT recipients mice
transplanted with bone marrow cells from AMPKa1/ mice but
not WT and AMPKa1+/ mice, demonstrated marked splenomeg-
aly 10 weeks post-transplantation (Fig. 3A). Histologic analysis re-
vealed that the red pulp was markedly expanded in the spleen of
mice transplanted with AMPKa1/ bone marrow cells compared
to that of mice transplanted with WT bone marrow cells (Fig. 3B).
We next examined the accumulation of iron in the spleen, which is
generated by the metabolism of heme. Prussian blue stainings of
spleen sections depicted an increased iron accumulation in the
spleen of mice transplanted with AMPKa1/ bone marrow cells
(fourfold increase) compared to those transplanted with WT bone
marrow cells (Fig. 3B and C). This was also true of the liver, where
in mice transplanted with AMPKa1/ bone marrow cells, there
was a twofold increase in iron deposition (Fig. 3D). We next ana-
lyzed the bilirubin levels in the blood plasma to determine a pos-
sible effect on RBC turnover. Indeed, unconjugated bilirubin
showed higher levels in the plasma of mice transplanted with
AMPKa1/ bone marrow cells (1.37 ± 0.13 lmol/l in mice trans-
planted with AMPKa1/ bone marrow cells, versus 0.35 ±
0.05 lmol/l in mice transplanted with WT bone marrow cells,
n = 3–4; P < 0.001), consistent with peripheral destruction of RBC.Fig. 2. Consequence of splenectomy in WT and AMPKa1/ mice. RBC count, Hb
concentration, hematocrit and reticulocyte numbers at baseline (b) and 40 and
90 days after splenectomy in WT and AMPKa1/ mice. Results are expressed as
means ± S.E.M. (n = 7–8); *P < 0.05; **P < 0.01; #P < 0.001 compared to AMPKa1/
baseline and $P < 0.0001 compared to WT mice on the respective day after
splenectomy.
s ± S.E.M. (n = 5–6); #P < 0.001 compared to WT; §P < 0.001 compared to AMPKa1+/
 mice.These results indicate that the anemia apparent in mice trans-
planted with AMPKa1/ bone marrow cells could be attributed,
at least in part, to an increased rate of uptake and subsequent
clearance of abnormal circulating RBC by the spleen.
Furthermore, lethally irradiated WT mice that were trans-
planted with hematopoietic cells derived from AMPKa1/ bone
marrow showed signiﬁcantly reduced RBC count, hematocrit and
hemoglobin concentration, and also increased RDW and reticulo-
cytosis compared to control recipients injected with either WT or
AMPKa1+/ bone marrow cells (Fig. 4A). Interestingly, RBC from
mice transplanted with AMPKa1/ bone marrow cells also dis-
played the same magnitude and spectrum of osmotic resistance
(Fig. 4B) as previously reported for AMPKa1/ RBC [6,7]. Hence,
the hematologic phenotype of AMPKa1/ mice was clearly reca-
pitulated in terms of blood parameters and functional properties of
RBC, suggesting that AMPKa1 plays an intrinsic role in RBC
homeostasis.
3.4. AMPKa1 is important for red cell membrane deformability
WeassessedRBCdeformabilitybyusingaLORCAanddetermined
the deformation index in relation to the shear stress applied on the
RBCmembrane surface. RBC deformability was signiﬁcantly altered
in AMPKa1/mice compared toWTmice for themajority of shear
stress rates studied (Fig. 5). Interestingly, AMPKa1was associated to
the red cell membrane as it is present in RBC ghostmembrane prep-
arations (Fig. 1A), consistent with confocal microscopy analysis of
Fig. 4. Hematologic parameters and functional properties of RBC after bone marrow
cells transplantation from AMPKa1/ mice into lethally irradiated WT recipients.
(A) Hematologic parameters in WT mice transplanted with bone marrow cells
derived fromWT (black bar), AMPKa1+/ (dashed bar) or AMPKa1/ (empty bar)
mice. Results are expressed as means ± S.E.M. (n = 7–8); **P < 0.01; #P < 0.001
compared to WT mice; P < 0.01; § P < 0.001 compared to AMPKa1+/mice (n = 5–
6). (B) Osmotic resistance of RBC from WT recipients transplanted with bone
marrow cells derived fromWT, AMPKa1+/ or AMPKa1/mice. Peripheral blood
was exposed to different concentration of NaCl (%) and hemolysis was assessed by
spectrometry of supernatant. Results are expressed as means ± S.E.M. (n = 5–6);
*P < 0.05; **P < 0.01; #P < 0.001 compared to WT mice; P < 0.05; P < 0.01;
§P < 0.001 compared to AMPKa1+/ mice.
Fig. 5. Reduced deformability of AMPKa1/ RBC. Deformability proﬁle of RBC
from WT (black bar) and AMPKa1/ (empty bar) mice in relation to the shear
stress (0.3–50 Pa). Results are expressed as means ± S.E.M. (n = 6); *P < 0.05;
**P < 0.01; #P < 0.001 compared to WT mice.
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cate that AMPKa1 could have a critical role in the control of mem-
brane ﬂexibility of RBC and in the microcirculation when the RBC
must enter into narrow capillaries.
4. Discussion
Our results show that anemia in AMPKa1/ mice is not
the result of impaired proliferation or maturation of theerythroid lineage as erythropoiesis is increased in both the
spleen and bone marrow of AMPKa1/ mice (Supplementary
Figs. 1 and 2). This enhanced stimulation of erythropoiesis in
AMPKa1/ mice is correlated with elevated concentration of
plasma erythropoietin [6,7]. In line with these observations, his-
tological analysis of AMPKa1/ spleen showed abnormal
expansion of the red pulp with a signiﬁcant increase in the num-
ber of erythroid precursors, indicating enhanced erythroid extra-
medullary erythropoiesis [7,8]. It is therefore likely that the
increase in spleen size is primarily a compensatory response to
the anemia of AMPKa1/ mice with a vigorous splenic eryth-
ropoiesis. Indeed, AMPKa1/ mice depend on the spleen for
adequate erythropoiesis as revealed by the worsening anemia
in splenectomized AMPKa1/ mice (Fig. 2). Furthermore, iron
accumulation in the spleen of AMPKa1/ mutant mice is
markedly increased [7], indicating that enlargement of the
spleen can also be attributed to an increased rate of uptake
and subsequent clearance of circulating AMPKa1/ RBC by
the spleen. Previous studies demonstrated that AMPKa1/
RBC have increased phosphatidylserine exposure at their surface
and must create a situation favorable to erythrophagocytosis,
leading to shortened lifespan [6,7]. All together, these results
suggest that the splenomegaly of AMPKa1/ mice is caused
by both enhanced erythrophagocytosis clearance of AMPKa1/
 RBC and expansion of extramedullary erythropoiesis in the
spleen.
In order to demonstrate the cell autonomous role of AMPKa1 in
the RBC in the setting of anemia, bone marrow transplantation of
AMPKa1/ bone marrow into WT congenic recipients was per-
formed. Chimeric mice were found to manifest splenomegaly with
decreased RBC count, hematocrit, hemoglobin concentration
(Fig. 4A) demonstrating an intrinsic role for AMPKa1 in RBC. This
was further conﬁrmed by osmotic resistance observed with RBC
from WT recipients mice transplanted with bone marrow cells
from AMPKa1/ mice (Fig. 4B).
In the circulation, RBC are highly pleomorphic and adopt a
broad spectrum of shapes, an important characteristic for main-
taining the survival of RBC under high shear conditions in the
vascular system. Remarkably, AMPKa1/ RBC are less deform-
able in response to shear stress than control RBC indicating lim-
ited structural ﬂexibility in the absence of AMPKa1 (Fig. 5).
These ﬁndings are suggestive of hemolytic anemia phenotype
caused by the absence of AMPKa1 activity in RBC leading to a
rigidiﬁcation of the cell membrane that possibly affects diffusion
into narrow capillaries and consequently, RBC homeostasis. Puta-
tive AMPK substrate proteins in RBC were recently identiﬁed
[12], including the band 3 protein from the red cell membrane
and enzymes involved in the oxidative stress response, which
may contribute to the molecular defects associated with the in-
creased membrane rigidity of AMPKa1/ RBC [7].
In conclusion, impaired function of AMPKa1 induces sufﬁcient
alterations in RBC structural ﬂexibility to affect their lifespan and
to incurably provoke their elimination from circulation.Acknowledgements
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